Liposomal curcumin and its application in cancer

Area of Science:

• Pharmacology
• Nanotechnology
• Oncology

Background:

• Curcumin (CUR), a polyphenol from turmeric, has shown potential in treating various cancers.
• CUR's therapeutic efficacy is hindered by poor solubility, low bioavailability, and rapid elimination.
• Novel drug delivery systems are crucial to enhance CUR's anti-cancer properties.

Purpose of the Study:

• To review the preparation methods of liposomal curcumin formulations.
• To explore the application of liposomal CUR in cancer therapy.
• To highlight the advantages of liposomes as a drug delivery system for CUR.

Main Methods:

• Literature review on liposomal CUR preparation techniques.
• Analysis of studies investigating liposomal CUR's anti-cancer effects.
• Comparison of liposomal CUR with conventional CUR formulations.

Main Results:

• Liposomal encapsulation significantly improves CUR's solubility and bioavailability.
• Liposomal CUR demonstrates enhanced growth inhibitory and pro-apoptotic effects on cancer cells.
• Liposomes are a well-studied and effective delivery system for CUR.

Conclusions:

• Liposomal CUR is a promising strategy for improving cancer treatment outcomes.
• Further research into liposomal CUR formulations can optimize its therapeutic potential.
• Liposomes offer a viable solution to CUR's delivery challenges in oncology.